secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001826667-25-000074
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus shareholders elect Wahlström and Matlin to board, ratify Grant Thornton
--------------------------------------------------------------------------------

- Mats Wahlström and David J. Matlin elected to three-year terms with 20,002,109 and 20,005,151 votes for, respectively; 5,978,753 broker non-votes each.
- Ratification of Grant Thornton as independent auditor for 2025: 26,445,528 for, 36,277 against, 994 abstain.
- 26,482,799 of 36,180,828 outstanding shares (73.2%) represented at the June 12, 2025 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000074/0001826667-25-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000074/tlsi-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer